Screener
PBE vs KBWB
Invesco Biotechnology & Genome ETF vs Invesco KBW Bank ETF
Key differences
- KBWB costs 0.23% less per year.
- KBWB is significantly larger than PBE — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, KBWB has delivered higher annualized returns.
- PBE has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| PBE | KBWB | |
|---|---|---|
| Annual cost (TER) | 0.58% | 0.35% |
| Fund size (AUM) | $247M | $5.5B |
| Since | 2005 | 2011 |
| Dividend yield | 1.09% | 2.06% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +35.8% | +37.1% |
| CAGR 3Y | +10.3% | +33.6% |
| CAGR 5Y | +3.5% | +8.1% |
| Sharpe 3Y | 0.41 | 1.19 |
| Volatility 1Y | 18.63% | 20.09% |
| Max drawdown | -37.84% | -50.27% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to PBE and KBWB
Explore further